Sepsis-associated acute kidney injury (SA-AKI) is a critical condition with significant clinical implications, yet there is a need for a predictive model that can reliably assess the risk of its development. This study is undertaken to bridge a gap in healthcare by creating a predictive model for SA-AKI with the goal of empowering healthcare providers with a tool that can revolutionize patient care and ultimately lead to improved outcomes.
Methods
A cohort of 615 patients afflicted with sepsis, who were admitted to the intensive care unit, underwent random stratification into 2 groups: a training set (n = 435) and a validation set (n = 180). Subsequently, a multivariate logistic regression model, imbued with nonzero coefficients via LASSO regression, was meticulously devised for the prognostication of SA-AKI. This model was thoughtfully rendered in the form of a nomogram. The salience of individual risk factors was assessed and ranked employing Shapley Additive Interpretation (SHAP). Recursive partition analysis was performed to stratify the risk of patients with sepsis.
Results
Among the panoply of clinical variables examined, hypertension, diabetes mellitus, C-reactive protein, procalcitonin (PCT), activated partial thromboplastin time, and platelet count emerged as robust and independent determinants of SA-AKI. The receiver operating characteristic curve analysis for SA-AKI risk discrimination in both the training set and validation set yielded an area under the curve estimates of 0.843 (95% CI: 0.805 to 0.882) and 0.834 (95% CI: 0.775 to 0.893), respectively. Notably, PCT exhibited the most conspicuous influence on the model's predictive capacity. Furthermore, statistically significant disparities were observed in the incidence of SA-AKI and the 28-day survival rate across high-risk, medium-risk, and low-risk cohorts (P < .05).
Conclusion
The composite predictive model, amalgamating the quintet of SA-AKI predictors, holds significant promise in facilitating the identification of high-risk patient subsets.
SingerMDeutschmanCSSeymourCW, et al.The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801-810. doi: https://doi.org/10.1001/jama.2016.0287.
2.
MooreJXDonnellyJP. Griffin R, et al. Defining sepsis mortality clusters in the United States. Crit Care Med. 2016;44(7):1380-1387. doi: https://doi.org/10.1097/CCM.0000000000001665.
3.
LubetzkyMAullMJCraig-SchapiroR, et al.Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: A report of consecutive cases from a New York city transplant center. Nephrol Dial Transplant. 2020;35(7):1250-1261. doi: 10.1093/ndt/gfaa154 doi:10.1093/ndt/gfaa154
ChenHLiYWuJ, et al.RIPK3 Collaborates with GSDMD to drive tissue injury in lethal polymicrobial sepsis. Cell Death Differ. 2020;27(9):2568-2585. doi: https://doi.org/10.1038/s41418-020-0524-1
6.
FaniFRegolistiGDelsanteM, et al.Recent advances in the pathogenetic mechanisms of sepsis-associated acute kidney injury. J Nephrol. 2018;31(3):351-359. doi: https://doi.org/10.1007/s40620-017-0452-4
BagshawSMUchinoSBellomoR, et al.Septic acute kidney injury in critically ill patients: Clinical characteristics and outcomes. Clin J Am Soc Nephrol. 2007;2(3):431-439. doi: https://doi.org/10.2215/CJN.03681106
9.
UchinoSKellumJABellomoR, et al.Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA. 2005;294(7):813-818. doi: https://doi.org/10.1001/jama.294.7.813
10.
GameiroJFonsecaJAJorgeS, et al.Neutrophil, lymphocyte and platelet ratio as a predictor of mortality in septic-acute kidney injury patients. Nefrologia (Engl Ed). 2020;40(4):461-468. doi: https://doi.org/10.1016/j.nefro.2019.11.006
11.
CavazzutiISerafiniGBusaniS, et al.Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock. Intensive Care Med. 2014;40(12):1888-1896. doi: https://doi.org/10.1007/s00134-014-3474-6
12.
MartinGS.Sepsis, severe sepsis and septic shock: Changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther. 2012;10(6):701-706. doi: https://doi.org/10.1586/eri.12.50
13.
SuLPanPYanP, et al.Role of vimentin in modulating immune cell apoptosis and inflammatory responses in sepsis. Sci Rep. 2019;9(1):5747. doi: https://doi.org/10.1038/s41598-019-42287-7
14.
CummingsMJBaldwinMRAbramsD, et al.Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York city: A prospective cohort study. Lancet. 2020;395(10239):1763-1770. doi: https://doi.org/10.1016/S0140-6736(20)31189-2
15.
DengFPengMLiJ, et al.Nomogram to predict the risk of septic acute kidney injury in the first 24 h of admission: An analysis of intensive care unit data. Ren Fail. 2020;42(1):428-436. doi: https://doi.org/10.1080/0886022X.2020.1761832
16.
FanCDingXSongY.A new prediction model for acute kidney injury in patients with sepsis. Ann Palliat Med. 2021;10(2):1772-1778. doi: https://doi.org/10.21037/apm-20-1117
17.
ZhouJBaiYWangX, et al.A simple risk score for prediction of sepsis associated-acute kidney injury in critically ill patients. J Nephrol. 2019;32(6):947-956. doi: https://doi.org/10.1007/s40620-019-00625-y
18.
HausfaterPRobert BoterNMorales IndianoC, et al.Monocyte distribution width (MDW) performance as an early sepsis indicator in the emergency department: Comparison with CRP and procalcitonin in a multicenter international European prospective study. Crit Care. 2021;25(1):227. doi: https://doi.org/10.1186/s13054-021-03622-5
19.
RuanLChenGYLiuZ, et al.The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: A meta-analysis and systematic review. Crit Care. 2018;22(1):316. doi: https://doi.org/10.1186/s13054-018-2236-1
20.
KhwajaA.KDIGO Clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012; 120(4):c179-c184. doi: https://doi.org/10.1159/000339789
21.
LundbergSMErionGChenH, et al.From local explanations to global understanding with explainable AI for trees. Nat Mach Intell. 2020;2(1):56-67. doi: https://doi.org/10.1038/s42256-019-0138-9
22.
BreimanL.Classification and RegressionChapman & Hall/ CRC; 1984
StasiAIntiniADivellaC, et al.Merging role of lipopolysaccharide binding protein in sepsis-induced acute kidney injury. Nephrol Dial Transplant. 2017;32(1):24-31. doi: https://doi.org/10.1093/ndt/gfw250
25.
GustotT.Multiple organ failure in sepsis: Prognosis and role of systemic inflammatory response. Curr Opin Crit Care. 2011;17(2):153-159. doi: https://doi.org/10.1097/MCC.0b013e328344b446
26.
LeviMde JongeEvan der PollT.Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation. Crit Care Med. 2001;29(7 Suppl):S90-S94. doi: https://doi.org/10.1097/00003246-200107001-00028
27.
EngelmannBMassbergS.Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2013;13(1):34-45. doi: https://doi.org/10.1038/nri3345
28.
WaldRMcArthurEAdhikariNK, et al.Changing incidence and outcomes following dialysis-requiring acute kidney injury among critically ill adults: A population-based cohort study. Am J Kidney Dis. 2015;65(6):870-877. doi: https://doi.org/10.1053/j.ajkd.2014.10.017
SongJCWangGZhangW, et al.Chinese Expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19. Mil Med Res. 2020;7(1):19. doi: https://doi.org/10.1186/s40779-020-00247-7
31.
XuZChengBFuS, et al.Coagulative biomarkers on admission to the ICU predict acute kidney injury and mortality in patients with septic shock caused by intra-abdominal infection. Infect Drug Resist. 2019;12:2755-2764. doi: https://doi.org/10.2147/IDR.S218592
32.
MenardCEKumarAHoustonDS, et al.Evolution and impact of thrombocytopenia in septic shock: A retrospective cohort study. Crit Care Med. 2019;47(4):558-565. doi: https://doi.org/10.1097/CCM.0000000000003644
33.
HosteEAJKellumJASelbyNM, et al.Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol. 2018;14(10):607-625. doi: https://doi.org/10.1038/s41581-018-0052-0
LiDZhouYYuJ, et al.Evaluation of a novel prognostic score based on thrombosis and inflammation in patients with sepsis: A retrospective cohort study. Clin Chem Lab Med. 2018;56(7):1182-1192. doi: https://doi.org/10.1515/cclm-2017-0863
SouzaACYuenPSStarRA.Microparticles: Markers and mediators of sepsis-induced microvascular dysfunction, immunosuppression, and AKI. Kidney Int. 2015;87(6):1100-1108. doi: https://doi.org/10.1038/ki.2015.26
38.
SemeraroFColucciMCaironiP, et al.Platelet drop and fibrinolytic shutdown in patients with sepsis. Crit Care Med. 2018;46(3):e221-e228. doi: https://doi.org/10.1097/CCM.0000000000002919
39.
ZouZChenSLiY, et al.Risk factors for renal failure and short-term prognosis in patients with spontaneous intracerebral haemorrhage complicated by acute kidney injury. BMC Nephrol. 2020;21(1):311. doi: https://doi.org/10.1186/s12882-020-01949-9
40.
MihajlovicDLendakDMiticG, et al.Prognostic value of hemostasis-related parameters for prediction of organ dysfunction and mortality in sepsis. Turk J Med Sci. 2015;45(1):93-98. doi: https://doi.org/10.3906/sag-1309-64
41.
MalhotraRKashaniKBMacedoE, et al.A risk prediction score for acute kidney injury in the intensive care unit. Nephrol Dial Transplant. 2017;32(5):814-822. doi: https://doi.org/10.1093/ndt/gfx026
42.
RannikkoJSyrjänenJSeiskariT, et al.Sepsis-related mortality in 497 cases with blood culture-positive sepsis in an emergency department. Int J Infect Dis. 2017;58:52-57. doi: https://doi.org/10.1016/j.ijid.2017.03.005
43.
InciardiRMAdamoMLupiL, et al.Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in northern Italy. Eur Heart J. 2020;41(19):1821-1829. doi: https://doi.org/10.1093/eurheartj/ehaa388
44.
ChenTWuDChenH, et al.Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. Br Med J. 2020;368:m1091. doi: https://doi.org/10.1136/bmj.m1295
45.
WangYZhangYLinH, et al.Risk factors for lymph node metastasis in rectal neuroendocrine tumors: A recursive partitioning analysis based on multicenter data. J Surg Oncol. 2021;124(7):1098-1105. doi: https://doi.org/10.1002/jso.26615.
46.
LiSWangYCaiH, et al.A good preoperative immune prognostic index is precits a better prognosis for locally advanced rectal cancer patients with ypTNM stage II who underwent radical resection after neoadjuvant chemoradiotherapy. Int J Colorectal Dis. 2023;38(1):184. doi: https://doi.org/10.1007/s00384-023-04474-x
47.
SamlowskiWEMajerMBoucherKM, et al.Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery. Cancer. 2008;113(9):2539-2548. doi: https://doi.org/10.1002/cncr.23857
48.
JiaDLiXLZhangQ, et al.A decision tree built with parameters obtained by computed tomographic pulmonary angiography is useful for predicting adverse outcomes in non-high-risk acute pulmonary embolism patients. Respir Res. 2019;20(1):187. doi: https://doi.org/10.1186/s12931-019-1160-5
49.
ShimazuiTNakadaTATateishiY, et al.Association between serum levels of interleukin-6 on ICU admission and subsequent outcomes in critically ill patients with acute kidney injury. BMC Nephrol. 2019;20(1):74. doi: https://doi.org/10.1186/s12882-019-1265-6
50.
ChawlaLSSeneffMGNelsonDR, et al.Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsis. Clin J Am Soc Nephrol. 2007;2(1):22-30. doi: https://doi.org/10.2215/CJN.02510706.
51.
JinKMuruganRSileanuFE, et al.Intensive monitoring of urine output is associated with increased detection of acute kidney injury and improved outcomes. Chest. 2017;152(5):972-979. doi: https://doi.org/10.1016/j.chest.2017.05.011.
52.
PrescottHCChangVWO'Brien JrJM, et al.Obesity and 1-year outcomes in older Americans with severe sepsis. Crit Care Med. 2014;42(8):1766-1774. doi: https://doi.org/10.1097/CCM.0000000000000336
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
